Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
17%
Ph not_applicable
3
50%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)

Trials by Status

recruiting117%
withdrawn117%
completed467%

Recent Activity

1 active trials
Showing 5 of 6
recruiting

Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema

NCT07295704
withdrawnnot_applicable

Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE

NCT05679180
completedphase_4

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

NCT03690947
completednot_applicable

Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

NCT05447117
completedphase_2

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

NCT03143192
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07295704

Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema

Recruiting
NCT05679180Not Applicable

Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE

Withdrawn
NCT03690947Phase 4

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

Completed
NCT05447117Not Applicable

Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

Completed
NCT03143192Phase 2

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

Completed
NCT04014556Not Applicable

Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6